Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06379321 · ClinicalTrials.gov registry record
Evaluation of Outcomes of the Triathlon Hinge Knee (THK) System
A clinical trial of Recurrence and Knee Arthropathy, sponsored by The Cleveland Clinic.
- Recruiting
- Registry status
- 200
- Enrollment target
- 2
- Study locations
NCT06379321: Recruiting study of Recurrence and Knee Arthropathy, sponsored by The Cleveland Clinic.
NCT06379321 is a study of Recurrence and Knee Arthropathy that is actively recruiting participants, run by The Cleveland Clinic. The registered enrollment target is 200 participants, below the 509-participant average among 8 other Recurrence trials with a reported enrollment target (61% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06379321, a study of Recurrence and Knee Arthropathy, is actively recruiting participants, sponsored by The Cleveland Clinic.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study is a prospectively and retrospectively enrolled, post-market, open-label, non-randomized, single institution evaluation of clinical outcomes of primary or revision knee surgery patients who meet the eligibility criteria and received devices from the Triathlon Hinge Knee System according to its indications for use (IFU). Clinical evaluation for all cases will include data collection of patient demographics, surgical details, early postoperative status, functional and clinical outcomes, and survivorship at 1, 2, 6, and 10-years.
Primary Outcome
To evaluate the survivorship of the Hinge Knee System at postoperatively. Survival is defined as the absence of aseptic revision to the implanted device.
Conditions Studied
Interventions
- DEVICE Triathlon Hinge Knee (THK) System
Study Locations (2)
Florida
- Cleveland Clinic Florida - Weston
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-05-10 |
| Est. Completion | 2034-05-10 |
What NCT06379321 shows while recruiting
NCT06379321 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 509-participant average among 8 other Recurrence trials with a reported enrollment target (61% lower).
The record links to 3 conditions, with Recurrence appearing as the primary indexed condition, and to 1 intervention - of which Triathlon Hinge Knee (THK) System is the first listed.
NCT06379321 reports a single indexed study location in Florida, Ohio.
Frequently Asked Questions
What is clinical trial NCT06379321 about?
NCT06379321 is a clinical study titled "Evaluation of Outcomes of the Triathlon Hinge Knee (THK) System". This study is a prospectively and retrospectively enrolled, post-market, open-label, non-randomized, single institution evaluation of clinical outcomes of primary or revision knee surgery patients who meet the eligibility criteria and received devices from the Triathlon Hinge Knee System according t...
What is the current status of trial NCT06379321?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2024-05-10. Estimated completion is 2034-05-10.
What conditions does trial NCT06379321 study?
This clinical trial studies the following conditions: Recurrence, Knee Arthropathy, Knee Infection.
What interventions are being tested in trial NCT06379321?
The interventions under investigation include: Triathlon Hinge Knee (THK) System (DEVICE).
Who is sponsoring clinical trial NCT06379321?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06379321 being conducted?
This trial has 2 study locations across Florida, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Recurrence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06379321's enrollment target sits among peer trials
200 6th of 8 higher than 3 of 8 other Recurrence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Recurrence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Endoscopic Resection of Large Colorectal Polyps: An Observational Cohort Study
RECRUITING
-
Association Between Exercise, Patient-Reported Outcomes, and Clinical Events in Adult Cancer Survivors
RECRUITING
-
xDRIVE for Florida-based Cancer Patients
RECRUITING · NA
-
AB-2100, an Integrated Circuit T Cell Therapy in Patients With Recurrent Clear-cell Renal Cell Carcinoma (ccRCC)
ACTIVE NOT RECRUITING · Phase 1
-
Cold Snare Endoscopic Mucosal Resection Trial
ACTIVE NOT RECRUITING · NA
-
Recurrence Markers, Cognitive Burden and Neurobiological Homeostasis in Late-Life Depression
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI